111 related articles for article (PubMed ID: 18538948)
1. Vessel size index magnetic resonance imaging to monitor the effect of antivascular treatment in a rodent tumor model.
Howe FA; McPhail LD; Griffiths JR; McIntyre DJ; Robinson SP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1470-6. PubMed ID: 18538948
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126.
Robinson SP; Howe FA; Griffiths JR; Ryan AJ; Waterton JC
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):872-9. PubMed ID: 17889267
[TBL] [Abstract][Full Text] [Related]
3. Rat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosis.
McPhail LD; McIntyre DJ; Ludwig C; Kestell P; Griffiths JR; Kelland LR; Robinson SP
Neoplasia; 2006 Mar; 8(3):199-206. PubMed ID: 16611413
[TBL] [Abstract][Full Text] [Related]
4. Assessment of tumor response to the vascular disrupting agents 5,6-dimethylxanthenone-4-acetic acid or combretastatin-A4-phosphate by intrinsic susceptibility magnetic resonance imaging.
McPhail LD; Griffiths JR; Robinson SP
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1238-45. PubMed ID: 17967313
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts.
Walker-Samuel S; Boult JK; McPhail LD; Box G; Eccles SA; Robinson SP
Int J Cancer; 2012 Mar; 130(6):1284-93. PubMed ID: 21469141
[TBL] [Abstract][Full Text] [Related]
6. Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry.
Robinson SP; Rijken PF; Howe FA; McSheehy PM; van der Sanden BP; Heerschap A; Stubbs M; van der Kogel AJ; Griffiths JR
J Magn Reson Imaging; 2003 Apr; 17(4):445-54. PubMed ID: 12655584
[TBL] [Abstract][Full Text] [Related]
7. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.
Seshadri M; Bellnier DA; Cheney RT
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1198-207. PubMed ID: 18954713
[TBL] [Abstract][Full Text] [Related]
9. Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging.
Kostourou V; Robinson SP; Whitley GS; Griffiths JR
Cancer Res; 2003 Aug; 63(16):4960-6. PubMed ID: 12941821
[TBL] [Abstract][Full Text] [Related]
10. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.
de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG
Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147
[TBL] [Abstract][Full Text] [Related]
11. Visualizing the acute effects of vascular-targeted therapy in vivo using intravital microscopy and magnetic resonance imaging: correlation with endothelial apoptosis, cytokine induction, and treatment outcome.
Seshadri M; Spernyak JA; Maiery PG; Cheney RT; Mazurchuk R; Bellnier DA
Neoplasia; 2007 Feb; 9(2):128-35. PubMed ID: 17356709
[TBL] [Abstract][Full Text] [Related]
12. Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.
Boult JK; Borri M; Jury A; Popov S; Box G; Perryman L; Eccles SA; Jones C; Robinson SP
NMR Biomed; 2016 Nov; 29(11):1608-1617. PubMed ID: 27671990
[TBL] [Abstract][Full Text] [Related]
13. Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent--experimental study in the rat.
Johansson L; Johnsson C; Penno E; Björnerud A; Ahlström H
Radiology; 2002 Oct; 225(1):97-103. PubMed ID: 12354991
[TBL] [Abstract][Full Text] [Related]
14. Single dose of the antivascular agent, ZD6126 (N-acetylcolchinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model.
McIntyre DJ; Robinson SP; Howe FA; Griffiths JR; Ryan AJ; Blakey DC; Peers IS; Waterton JC
Neoplasia; 2004; 6(2):150-7. PubMed ID: 15140404
[TBL] [Abstract][Full Text] [Related]
15. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
Turetschek K; Huber S; Floyd E; Helbich T; Roberts TP; Shames DM; Tarlo KS; Wendland MF; Brasch RC
Radiology; 2001 Feb; 218(2):562-9. PubMed ID: 11161179
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
[TBL] [Abstract][Full Text] [Related]
17. In vivo assessment of tumoral angiogenesis.
Troprès I; Lamalle L; Péoc'h M; Farion R; Usson Y; Décorps M; Rémy C
Magn Reson Med; 2004 Mar; 51(3):533-41. PubMed ID: 15004795
[TBL] [Abstract][Full Text] [Related]
18. The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: a comparative assessment using MRI and MRS.
Breidahl T; Nielsen FU; Stødkilde-Jørgensen H; Maxwell RJ; Horsman MR
Acta Oncol; 2006; 45(3):306-16. PubMed ID: 16644574
[TBL] [Abstract][Full Text] [Related]
19. Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
Bentzen L; Vestergaard-Poulsen P; Nielsen T; Overgaard J; Bjørnerud A; Briley-Saebø K; Horsman MR; Ostergaard L
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1208-15. PubMed ID: 15752903
[TBL] [Abstract][Full Text] [Related]
20. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats.
Kaim AH; Wischer T; O'Reilly T; Jundt G; Fröhlich J; von Schulthess GK; Allegrini PR
Radiology; 2002 Dec; 225(3):808-14. PubMed ID: 12461265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
